PerkinElmer, Inc. (United States) (PKI)
| Market Cap | 15.84B |
| Revenue (ttm) | 4.44B |
| Net Income (ttm) | 1.07B |
| Shares Out | 112.03M |
| EPS (ttm) | 9.56 |
| PE Ratio | 14.77 |
| Forward PE | 15.24 |
| Dividend | $0.28 |
| Dividend Yield | 0.20% |
| Trading Day | May 13 |
| Last Price | $141.27 |
| Previous Close | $137.86 |
| Change ($) | 3.41 |
| Change (%) | 2.47% |
| Day's Open | 138.90 |
| Day's Range | 138.09 - 141.99 |
| Day's Volume | 672,790 |
| 52-Week Range | 88.40 - 162.54 |
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer, announced that its T-SPOT®.COVID test will...
PerkinElmer (PKI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PerkinElmer's (PKI) first-quarter results benefit from strong segmental performance.
Shares of PerkinElmer (NYSE:PKI) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 455.22% year over year to $3.72, which beat the estima...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a virtual Investor and Analyst D...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the first quarter ended April 4, 2021....
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock April 29, 2021. This dividend is payabl...
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-S...
PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at Diagnostics segment.
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec, a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-...
Here we discuss three MedTech subsectors, which encourage us with their consistency through the pandemic year and are likely to have continued with their winning streak in Q121.
PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. is supporting the PROXIDRUGS Consortium studying the body's own cell protein recycling system to fight disease.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Securities 2021 V...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of ...
Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.
PerkinElmer's (PKI) CRISPRi will help scientists get a firmer foothold in the biological pathways, processes and pathologies of disease.
WALTHAM, Mass.--(BUSINESS WIRE)--Horizon Discovery, A PerkinElmer, Inc. Company Expands Gene Modulation Portfolio With Industry First CRISPRi Reagents
PerkinElmer (PKI) continues to gain traction for solid product portfolio and improving margins. However, forex is a woe
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer announced its Signals™ platform is expanding in the biologics drug discovery space through a collaboration with Insightful Science.
PerkinElmer's (PKI) introduction of two comprehensive solutions is likely to strengthen its COVID-19 testing portfolio further.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acq...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI) today announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Seque...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer adds state-of-the-art columns and chemistries to its LC consumables, instrument and software portfolio to deliver end-to-end solutions.
The stock price of PerkinElmer Inc., a Waltham-based company focused on diagnostics, life sciences, and applied services markets, is up roughly 2x from the levels it was at on March 23, 2020, when broad...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate ...
Since going public just over three years ago, Quanterix Corp. (NASDAQ:QTRX) shares have quadrupled to about $63. Recently, the Billerica, Massachusetts-based diagnostics company closed another public of...
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock?
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Barclays Global Health...
Is PerkinElmer (PKI) a great pick from the value investor's perspective right now? Read on to know more.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antig...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory's (VBL)...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 41st Annual Cowen Heal...
Final Trades: Tilray, Cleveland-Cliffs, Fortive & more
The "Halftime Report" traders give their top picks to watch for the second half.
NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Oxford...
Selling shovels doesn't get stale if the gold rush never ends.
PerkinElmer's (PKI) fourth-quarter results benefit from strong segmental performance.
The short answer: Increased demand for COVID-19 testing.
PerkinElmer (PKI) delivered earnings and revenue surprises of 9.70% and 7.69%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of PerkinElmer (NYSE:PKI) moved higher by 0.1% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 193.33% over the past year to $3.96, which ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended...
PerkinElmer (NYSE:PKI) unveils its next round of earnings this Tuesday, February 02. Here is Benzinga's everything-that-matters guide for the earnings announcement.
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is paya...
Robust sales growth is the key to survival in today's fast changing and highly competitive operating backdrop. Let's check Crown Holdings (CCK), Rockwell Automation (ROK), PerkinElmer (PKI), KeyCorp (KE...
Top Ranked Growth Stocks to Buy for January 27th
PerkinElmer's (PKI) fourth-quarter results are likely to reflect strong performance at Diagnostics segment.
PerkinElmer is absolutely on fire as preliminary fourth quarter results reveal. PerkinElmer is not a one-trick pony. It has been a long-term value creator for investors.
About PKI
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, ... [Read more...]
| Industry Diagnostics & Research | Founded 1937 |
| CEO Prahlad Singh | Employees 14,000 |
| Stock Exchange NYSE | Ticker Symbol PKI |
Financial Performance
In 2020, PerkinElmer's revenue was $3.78 billion, an increase of 31.18% compared to the previous year's $2.88 billion. Earnings were $727.89 million, an increase of 219.87%.
Analyst Forecasts
According to 16 analysts, the average rating for PerkinElmer stock is "Buy." The 12-month stock price forecast is 157.57, which is an increase of 11.54% from the latest price.